Pillar Biosciences Incorporated

Pillar Biosciences Incorporated is a biotechnology company based in Natick, Massachusetts, founded in 2014. The company specializes in next-generation sequencing (NGS) diagnostics aimed at precision oncology and Decision Medicine™. It develops innovative, automatable technologies such as SLIMamp® and PiVAT® to facilitate rapid and cost-effective genomic tumor profiling, therapy selection, and recurrence monitoring. Pillar's mission is to make precision medicine accessible globally by providing streamlined, affordable clinical NGS workflows. Pillar offers a range of over 20 NGS testing kits in both in-vitro diagnostic (IVD) and research-use-only (RUO) formats, with additional products in development. Their solutions support the oncology ecosystem by delivering clinically actionable insights throughout patient care, from initial profiling to treatment guidance. The company collaborates with various healthcare providers, clinical labs, and biopharma companies, including a strategic partnership with Illumina for sequencing and bioinformatics.